Continuous-combined oral estradiol/drospirenone has no detrimental effect on cognitive performance and improves estrogen deficiency symptoms in early postmenopausal women: a randomized placebo-controlled trial. [electronic resource]
Producer: 20140422Description: 1020-6 p. digitalISSN:- 1530-0374
- Androstenes -- administration & dosage
- Blood Pressure -- drug effects
- Body Mass Index
- Body Weight -- drug effects
- Cognition -- drug effects
- Double-Blind Method
- Drug Combinations
- Estradiol -- administration & dosage
- Estrogen Replacement Therapy
- Female
- Humans
- Magnetic Resonance Imaging
- Middle Aged
- Placebos
- Postmenopause -- physiology
- Uterine Hemorrhage -- chemically induced
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.